Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2022 | 3 |
2023 | 1 |
2024 | 1 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
From Therapy Resistance to Targeted Therapies in Prostate Cancer.
Front Oncol. 2022 May 24;12:877379. doi: 10.3389/fonc.2022.877379. eCollection 2022.
Front Oncol. 2022.
PMID: 35686097
Free PMC article.
Review.
Repurposing Old Drugs into New Epigenetic Inhibitors: Promising Candidates for Cancer Treatment?
Moreira-Silva F, Camilo V, Gaspar V, Mano JF, Henrique R, Jerónimo C.
Moreira-Silva F, et al.
Pharmaceutics. 2020 Apr 29;12(5):410. doi: 10.3390/pharmaceutics12050410.
Pharmaceutics. 2020.
PMID: 32365701
Free PMC article.
Review.
Item in Clipboard
Epigenetically-regulated miR-30a/c-5p directly target TWF1 and hamper ccRCC cell aggressiveness.
Outeiro-Pinho G, Barros-Silva D, Moreira-Silva F, Lobo J, Carneiro I, Morais A, Martins EP, Gonçalves CS, Costa BM, Correia MP, Henrique R, Jerónimo C.
Outeiro-Pinho G, et al. Among authors: moreira silva f.
Transl Res. 2022 Nov;249:110-127. doi: 10.1016/j.trsl.2022.06.009. Epub 2022 Jun 11.
Transl Res. 2022.
PMID: 35697274
Item in Clipboard
Hydralazine and Panobinostat Attenuate Malignant Properties of Prostate Cancer Cell Lines.
Pacheco MB, Camilo V, Lopes N, Moreira-Silva F, Correia MP, Henrique R, Jerónimo C.
Pacheco MB, et al. Among authors: moreira silva f.
Pharmaceuticals (Basel). 2021 Jul 13;14(7):670. doi: 10.3390/ph14070670.
Pharmaceuticals (Basel). 2021.
PMID: 34358096
Free PMC article.
Item in Clipboard
EHMT2/G9a and EZH2: Epimarkers in testicular germ cell tumors.
Estevão-Pereira H, Guimarães-Teixeira C, Flores BCT, Moreira-Silva F, Tavares NT, Guimarães R, Braga I, Maurício J, Henrique R, Jerónimo C, Lobo J.
Estevão-Pereira H, et al. Among authors: moreira silva f.
Andrology. 2024 Feb 21. doi: 10.1111/andr.13604. Online ahead of print.
Andrology. 2024.
PMID: 38380739
Item in Clipboard
Novel Insights on the Role of Epigenetics in Androgen Receptor's Expression in Prostate Cancer.
Camilo V, Pacheco MB, Moreira-Silva F, Outeiro-Pinho G, Gaspar VM, Mano JF, Marques CJ, Henrique R, Jerónimo C.
Camilo V, et al. Among authors: moreira silva f.
Biomolecules. 2023 Oct 14;13(10):1526. doi: 10.3390/biom13101526.
Biomolecules. 2023.
PMID: 37892208
Free PMC article.
Item in Clipboard
G9a inhibition by CM-272: Developing a novel anti-tumoral strategy for castration-resistant prostate cancer using 2D and 3D in vitro models.
Moreira-Silva F, Outeiro-Pinho G, Lobo J, Guimarães R, Gaspar VM, Mano JF, Agirre X, Pineda-Lucena A, Prosper F, Paramio JM, Henrique R, Correia MP, Jerónimo C.
Moreira-Silva F, et al.
Biomed Pharmacother. 2022 Jun;150:113031. doi: 10.1016/j.biopha.2022.113031. Epub 2022 Apr 25.
Biomed Pharmacother. 2022.
PMID: 35483199
Free article.
Item in Clipboard
Cite
Cite